Galena Biopharma Inc. agreed to settle all of its outstanding disputes with Cardinal Health Inc. over a product swap agreement.
Under the deal, Galena Biopharma will pay $500,000 to Cardinal Health. In turn, Cardinal Health will destroy all of the Zuplenz product returned due to the product swap. The related product swap agreement was also terminated as of the settlement date.
The companies entered into the agreement Sept. 25.